MaquiBright Icon: dry eyes

MaquiBright® A superior ingredient for eye health

Vision is one of our most important senses. The eye is a very complex organ and eye health encompasses various aspects with as many factors that can influence our sight. Not only ambient dry air due to air conditioners or overheated rooms, long working hours at screens, but also lifestyle-related oxidative stress and ageing in general, can cause dry eyes.

MaquiBright® significantly enhances tear fluid production and relieves dry eye-related symptoms, tackling both objective and subjective symptoms. MaquiBright® helps to alleviate the source of dry eyes by not only masking the symptoms but addressing the causes directly.

Unique Features

  • Restoration of healthy tear fluid generation
  • Relieves dry eye-related symptoms like stiff shoulders
  • Comfortable and safe alternative to artificial tear drops


MaquiBright® is manufactured from selected fresh maqui berries under strict GMP conditions. The extract is standardised to bear a minimum of 25 % delphinidins and a minimum of 35 % total anthocyanins.

MaquiBright® shows clinically proven bioavailability of key active ingredients.

U.S. Structure/Function Claims: 

  • MaquiBright® naturally and safely supports eye health with its high antioxidant and anthocyanin content.**
  • Helps to nourish the eyes and naturally restores the normal production of tears.**
  • Potent antioxidant that helps to support the eyes’ response to oxidative stress.**

* Issued or pending patents derived from WO2014098092A1 are licensed from Oryza Oil & Fat Chemical Co., Ltd., Japan

*** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


Market ApplicationsDetailsReferences
Dry eye symptomsMaquiBright® restores tear fluid generation in people with dry eye symptoms.
Hitoe et al., 2014

MaquiBright® delphinidins quench oxidative stress and hence restore healthy tear fluid production.Nakamura et al., 2014
MaquiBright® supresses photoreceptor cell death by inhibiting production of reactive oxygen species.Tanaka et al., 2013
MaquiBright® significantly enhances tear fluid production and relieves dry-eye related symptoms.
Yamashita et al., 2018
Contact us
Graphic: career at Anklam Extrakt GmbH

Contact us

Please fill out all mandatory fields.

Your email address is invalid.

There has been an error. Please try again later.

Thank you for your message.

* Required Fields

Thanks for your request, we get in touch with you shortly.